Synthesis and biological evaluation of nucleoside analogues having 6-chloropurine as anti-SARS-CoV agents.
Masahiro Ikejiri, Masayuki Saijo, Shigeru Morikawa, Shuetsu Fukushi, Tetsuya Mizutani, Ichiro Kurane, Tokumi Maruyama
文献索引:Bioorg. Med. Chem. Lett. 17 , 2470-3, (2007)
全文:HTML全文
摘要
Nucleoside analogues that have 6-chloropurine as the nucleobase were synthesized and evaluated for anti-SARS-CoV activity by plaque reduction and yield reduction assays in order to develop novel anti-SARS-CoV agents. Among these analogues, two compounds, namely, 1 and 11, exhibited promising anti-SARS-CoV activity that was comparable to those of mizoribine and ribavirin, which are known anti-SARS-CoV agents. Moreover, we observed several SAR trends such as the antiviral effects of the 6-chloropurine moiety, unprotected 5'-hydroxyl group and benzoylated 5'-hydroxyl group.
相关化合物
相关文献:
2009-01-01
[Bioorg. Med. Chem. Lett. 19 , 6433-6, (2009)]
2010-01-01
[Bioorg. Med. Chem. Lett. 20(10) , 3098-102, (2010)]
2005-03-29
[Biochemistry 44(12) , 4850-60, (2005)]
2004-04-30
[J. Org. Chem. 69(9) , 3208-11, (2004)]
2005-01-01
[Molecules 10(2) , 508-15, (2005)]